Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Great rise today guys... Hopefully followed by some positive news from IMM. Hopefully this is the start of our road to recovery.
A pitty Nobinpus did not buy some at .10... Now it would cost him nearly double to become an investor.. Ohhh well, maybe some day Nobinpus, you will actually invest in IMM or some other share in stead of pretending...
So sweet is the apple that is starting to grow. Such a shame you never ever took a bite Nobinpus..
Enjoy your rise guys!
I am currently enjoying mine ; )
Very Strong Buy....
Frits
This is going up faster than my first birds drawers, when she hear her mum and dad coming home early from long weekend in Ullapool.
Nashing out her tenement window, down the drainpipe and across several back gardens to escape to live another day. I hope it does not go down as quick as my tadger did that cool winters night..
Starting to look more positive here. Could do with some positive news from IMM to shore up this rise.
Hint Hint Tim.... Chop Chop Fella..
Where is Nobinpus when we need him, could do with a laugh from our local VI..
Good luck all
Frits..
ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company provides an update on its clinical development collaboration agreement for its Nucant cancer programme, with Incanthera Limited ("Incanthera"), a specialist oncology development company. As announced on 7 December 2018, ImmuPharma alongside Incanthera are making good progress in finalising the 'Definitive Licence Agreement'. It has been agreed between both companies to extend the exclusivity period, which was initially granted to 31 December 2018, to 31 March 2019, in order to finalise the remaining parts of the agreement. It is now envisaged that the 'Definitive Licence Agreement' will be finalised in the first quarter of 2019 and as such, a further update on this collaboration will be announced in due course. Keep faith It's just a matter of time Frits
It sounds like your on the same boat as me. I bought in high and have suffered. We were unfortunate that the placebo groups medication masked the endpoint. The drug works. The mechanism of action is unique and in medical terms revolutionary. I still have faith that Lupazor or its mode of action in how it works will be developed and will go to market. There is too much to loose regards patient treatment as well as a profitable market. The offshoots from this mode of treatment is massive regards treating other diseases. Have faith my friend, we are still here. If there is any indication that this will go to market or be advanced the current price will be but a distant memory. Good luck Fritz
Again, for the multiple time, the question is again asked..
Why is Nolupus here?
Nolupus has admitted, on several occasions to the fact he is not even invested in this company but talks, discusses and infers with anyone who is prepared to listen, that he is an actual investor.
To be honest, its rather sad and pathetic..
So much to be gained by this gem of a share.. an 11.58% rise is making for a very tempting offer to to top up and average down...
Good Luck all. Especially to the LTH who are stuck like me with an average in the mid .50..
Here's hoping guys
Frits
What a lovely thing to behold.
The color Blue is golden to my eyes in more ways than one.
Dallo, while I am always fully supportive of a balanced view on any board as there is always two sides to a coin. I am sorry but I have to respectfully disagree with your comments regards Nolupus. That poster has been nothing but abusive, has constantly posted several comments, that on several occasions have fringe on being labile. He has never posted any balanced view on IMM. He has been passively aggressive since I have been on this board an extended period of time.
What is most strange, is that Nolupus has admitted on several occasions to the fact he is not even invested in this company but talks, discusses and infers with anyone who is prepared to listens, that he is an actual investor. When he is prompted to answer why he is hear he go surprisingly goes quite and disappears for several days. If you stay around long enough, you will come to understand my comments. He has had more bans and complaints than I care to remember.
Anyway, enough about that.
As I have said and maintained since my time here, there has been to much time, money and effort has gone in to this drug for it to fail at this stage.
Good luck all and enjoy this small rise. Hopefully we will have more blue in the not to distant future.
Regards
Frits.
Hope it all pans out for you long terms holders and you get some positive news.
Frits
What a golden opportunity for a large Pharma to take out potential competition and gain a drug that has passed two phase three trials.
It only needs a bit work/clarification to get it over the last hurdle. This is far from over in my view, but this is AIM and anything could happen.
I for one will hold till this all becomes clear as to how this will play out.
Frits
11. Oct 17: In PIII Revive-2 study, iclaprim achieved primary endpoint of non-inferiority against vancomycin (current standard of care), with clinical cure in 78% (vancomycin result not stated). Resolution/ near resolution at end of therapy was achieved in 54.6% and 55.4%, respectively [20].
16. Jan 19: Company are seeking partners to support commercialisation in the EU. [24]
Personnel dont see this being thrown to the dogs at this stage in the game.
There is more than one way to skin a cat in the dark.
Frits
There will be a cut of level regards liver toxicity that the FDA has and this has been breached. All drugs cause a degree of toxicity at varying degrees. We must be able to find out from the trial what ours was as well as what the cut of or level of concern the FDA has. The Doc that was on earlier may able to assist with the data interpretation. Sure there is someone here who can locate both the trial data as well as the FDA risk - benefit guidelines for liver toxicity. I personally think this has a story to tell. Have a good weekend all. Frits I
Being invested in IMM with enough to buy 2 new decent family cars, Guys I feel your pain. However, to me this looks like a massive over reaction. I still hold my IMM stock, to see a fall due to the placebo patient's current medication masking the placebo effect was an over reaction and I am still confident it will rise massivley on positive news which is hopefully arriving soon.
My point being , you guys should also hold and ride the storm. Lots of common sense posts here today regards holding. Its gaining some ground back and I can see this clear 10p today. Would expect a further rise tomorrow. Its gone too far down the road to trip and fall at the last hurdle.
Good luck all
Let's hope this year is more productive than last year. Still quietly confident is this share Too much work and time has been invested too let this go south because of a trail that failed to take in to account the current meds of the trial patients which tainted and mislead the results. Onward and upward guys Have a good weekend. Crits
Its been a very positive rise this week for IMM. As I have mentioned on several occasions, it's just a matter of time.
I hope as lot of you are making your way back to your initial average buy in. I am certainly going in the right direction but still have some way to go.
I am unsure what is driving this north.
* A possible takeover,
* Positive news on Lupuzor?
* A joint venture with a large pharma?
* The stock correcting to a more realistic position?
I really have no idea, to be honest, I dont really care as long as it continues to go north. As I have stated on several occasions, there is NO other drug out there that is as close to addressing Lupus as Lupuzor. We know why it did not meet its end point, it certainly was not due to it not working or not being safe.
We also have to remember the potential spins offs for treating other medical conditions.
Hold fast guys, its just a matter of time.
Have a pleasant weekend.
Frits.
Can you all try and keep the posts relative to Hurricane Energy.
I am not interested in Pish comments from one poster to another about complete and utter keek.
Its like a bunch of fish wives at a laundry talking a pile of complete and utter s hi te. So many pointless posts on this BB with so many trying to appear intelligent through their posts and completely failing.
Keep it simple and too the point. Its not rocket science.
Regards
Frits.
mmuPharma PLC (AIM: IMM.L), the specialist drug discovery and development company, announces that the Directors are aware of the proposed merger of its current nominated adviser ("NOMAD"), Northland Capital Partners ("Northland") with SP Angel Corporate Finance LLP. The Directors have also been informed that Northland has voluntarily agreed to relinquish its NOMAD status and will be removed from the register of NOMADs with effect from 7am (GMT) on 1 February 2019.
In accordance with AIM Rule 1, the Company is required to appoint a new NOMAD by 1 February 2019, if not, the Exchange will suspend trading in the Company's AIM Securities. If the Company does not appoint a replacement NOMAD by 4 March 2019, the admission of its AIM Securities will be cancelled.
The Company has commenced the process to appoint a new NOMAD and will make a further announcement in due course.
Frits
# Trades = 29
Vol. Sold = 196,690
Vol. Bought = 218,744
22,00 more shares bought than sold and we are down -3.13% .. Go figure!
WTF... Its pathetic
We will have our day guys. Don't listen to these numb nuts. They dont know what day of the week it is! Hell, they are not even invested in IMM! They are only here to cause disruption on the board.
Again for the slow and mentally challenged. Quote "In patients who had anti-dsDNA autoantibodies (a recognised biomarker for Systemic Lupus Erythematosus ('SLE')), Lupuzor™ demonstrated a superior response rate over placebo (61.5% vs 47.3%, p = 0.0967). In addition, 7.6% of these patients in the Lupuzor™ group went into full remission versus none in the placebo group"
Just be patient, this will come good.
There is no other drug on the market that has minimal side effects and has statistically proven results showing that it works. IMM board would not be continuing with this as their flagship and pursing various methods to test it if they did not have faith that it wont go to market. We know it failed due to the various other meds that the placebo group was on. That was the failure not ensuring that this was not addressed prior to the phase III trial. It should have been considered and but it was not. In fact, this is what is causing the majority of Lupus studies to fail, hence the reason the FDA is looking at changing the parameters regards this type of trial.
All the best
Frits